Bladder Cancer Clinical Trials in Kansas City, Kansas
9 recruitingKansas City, Kansas
Showing 1–9 of 9 trials
Recruiting
Phase 2
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Stage I Bladder Cancer AJCC v8Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
National Cancer Institute (NCI)160 enrolled113 locationsNCT06770582
Recruiting
Phase 1
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non Muscle Invasive Bladder Cancer
Pfizer294 enrolled53 locationsNCT07206225
Recruiting
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Bladder Cancer
University of Kansas Medical Center1,000 enrolled1 locationNCT03413982
Recruiting
Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
NRG Oncology486 enrolled191 locationsNCT07097142
Recruiting
Phase 1Phase 2
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Non-muscle Invasive Bladder Cancer With Carcinoma in SituSuperficial Bladder Cancer
enGene, Inc.350 enrolled100 locationsNCT04752722
Recruiting
Blue Light Cystoscopy With Cysview® Registry
Bladder Cancer
Photocure4,400 enrolled23 locationsNCT02660645
Recruiting
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
Bladder Cancer
University of Kansas Medical Center30 enrolled2 locationsNCT06721260
Recruiting
Phase 2
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Bladder Cancer
University of Kansas Medical Center48 enrolled2 locationsNCT06493370
Recruiting
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
SurgeryBladder Cancer
University of Kansas Medical Center20 enrolled1 locationNCT04979156